IBDEI0MB ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10029,2)
 ;;=^5004174^F02.81
 ;;^UTILITY(U,$J,358.3,10030,0)
 ;;=G91.2^^39^421^23
 ;;^UTILITY(U,$J,358.3,10030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10030,1,3,0)
 ;;=3^NPH w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,10030,1,4,0)
 ;;=4^G91.2
 ;;^UTILITY(U,$J,358.3,10030,2)
 ;;=^5004174^F02.80
 ;;^UTILITY(U,$J,358.3,10031,0)
 ;;=G30.8^^39^421^5
 ;;^UTILITY(U,$J,358.3,10031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10031,1,3,0)
 ;;=3^Alzheimer's Diseases NEC
 ;;^UTILITY(U,$J,358.3,10031,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,10031,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,10032,0)
 ;;=G31.09^^39^421^16
 ;;^UTILITY(U,$J,358.3,10032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10032,1,3,0)
 ;;=3^Frontotemporal Dementia NEC
 ;;^UTILITY(U,$J,358.3,10032,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,10032,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,10033,0)
 ;;=G20.^^39^421^24
 ;;^UTILITY(U,$J,358.3,10033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10033,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/ Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,10033,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,10033,2)
 ;;=^5003770^F02.81
 ;;^UTILITY(U,$J,358.3,10034,0)
 ;;=G20.^^39^421^25
 ;;^UTILITY(U,$J,358.3,10034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10034,1,3,0)
 ;;=3^Parkinson's Disease w/ Dementia w/o Behavioral Disturbances
 ;;^UTILITY(U,$J,358.3,10034,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,10034,2)
 ;;=^5003770^F02.80
 ;;^UTILITY(U,$J,358.3,10035,0)
 ;;=G31.01^^39^421^26
 ;;^UTILITY(U,$J,358.3,10035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10035,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,10035,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,10035,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,10036,0)
 ;;=G23.1^^39^421^28
 ;;^UTILITY(U,$J,358.3,10036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10036,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,10036,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,10036,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,10037,0)
 ;;=Z79.2^^39^422^1
 ;;^UTILITY(U,$J,358.3,10037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10037,1,3,0)
 ;;=3^Antibiotics
 ;;^UTILITY(U,$J,358.3,10037,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,10037,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,10038,0)
 ;;=Z79.01^^39^422^2
 ;;^UTILITY(U,$J,358.3,10038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10038,1,3,0)
 ;;=3^Anticoagulants
 ;;^UTILITY(U,$J,358.3,10038,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,10038,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,10039,0)
 ;;=Z79.02^^39^422^3
 ;;^UTILITY(U,$J,358.3,10039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10039,1,3,0)
 ;;=3^Antiplatelets/Antithrombotics
 ;;^UTILITY(U,$J,358.3,10039,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,10039,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,10040,0)
 ;;=Z79.82^^39^422^4
 ;;^UTILITY(U,$J,358.3,10040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10040,1,3,0)
 ;;=3^Aspirin
 ;;^UTILITY(U,$J,358.3,10040,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,10040,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,10041,0)
 ;;=Z79.4^^39^422^6
 ;;^UTILITY(U,$J,358.3,10041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10041,1,3,0)
 ;;=3^Insulin
 ;;^UTILITY(U,$J,358.3,10041,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,10041,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,10042,0)
 ;;=Z79.1^^39^422^9
 ;;^UTILITY(U,$J,358.3,10042,1,0)
 ;;=^358.31IA^4^2
